C0019134 - A substance that slows the formation of blood clots. Heparin is made by the liver, lungs, and other tissues in the body and can also made in the laboratory. Heparin may be injected into muscle or blood to prevent or break up blood clots. It is a type of anticoagulant.

home UMLS 2020

293,031 терминов и синонимов из MeSH и LOINC

Поиск по CUI	Поиск по CODE
Поиск по одному или нескольким словам или частям слов

Lang Dictionary CODE			LUI	preferred no	SUI	preference Yes / No	Terms, descriptions
							CUI C0019134

Russian	Medical Subject Headings Russian	D006493	L3344571	preferred	S3872050	Y	ГЕПАРИН
Russian	Medical Subject Headings Russian	D006493	L0894399	no	S1098216	Y	GEPARIN
Russian	Medical Subject Headings Russian	D006493	L1508038	no	S1803947	Y	AL'FA-GEPARIN
Russian	Medical Subject Headings Russian	D006493	L1521322	no	S1817231	Y	GEPARINOVAIA KISLOTA
Russian	Medical Subject Headings Russian	D006493	L3337810	no	S3865292	Y	АЛЬФА-ГЕПАРИН
Russian	Medical Subject Headings Russian	D006493	L3344583	no	S3872057	Y	ГЕПАРИНОВАЯ КИСЛОТА
	Medical Subject Headings				A0067387	AT38138347	A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.
	(CPTSP) CRISP Thesaurus				A0480761	AT51220322	poly(glucosamine sulfate-glucuronic acid); endogenous mucopolysaccharide with antithrombin and lipotropic activities; USP injection is used as an anticoagulant.
	(SPN) Standard Product Nomenclature				A0711327	AT20134748	Enzyme preparations are products that are used in the histopathology laboratory for the following purposes: (1) To disaggregate tissues and cells already in established cultures for preparation into subsequent cultures (e.g., trypsin); (2) To disaggregate fluid specimens for cytological examination (e.g., papain for gastric lavage or trypsin for sputum liquefaction); (3) To aid in the selective staining of tissue specimens (e.g., diastase for glycogen determination).
	Medical Subject Headings Czech				A13062347	AT231378529	Látka, která snižuje srážení krve (antikoagulační účinek) aktivací antitrombinu. Vzniká např. v játrech a v některých bílých krvinkách. Podává se v lékové formě při léčbě trombózy či k její profylaxi (tzv. heparinizace), často ve formě tzv. nízkomolekulárních heparinů (např. dalteparin, nadroparin, enoxaparin, parnaparin), které působí zejm. na faktor X, a neovlivňují tak celkovou hemokoagulaci, a proto mají nižší riziko vzniku nežádoucího krvácení. Kromě krvácení patří k vzácnějším nežádoucím účinkům vznik trombocytopenie, po dlouhodobějším podávání se zvyšuje riziko osteoporózy. Efektivnost léčby se monitoruje zejm. aPTT koagulačním testem. Antidotem při předávkování je protaminsulfát. (cit. Velký lékařský slovník online, 2017 http://lekarske.slovniky.cz)
	NCI Thesaurus				A7571021	AT197957783	A sulfur-rich glycosaminoglycan with anticoagulant property. Heparin binds to antithrombin III to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors, such as factors IX, X, XI, and XII, thereby preventing the polymerization of fibrinogen to fibrin and the subsequent formation of clots.
	NCI NCI Dictionary of Cancer Terms				A7571021	AT198056929	A substance that slows the formation of blood clots. Heparin is made by the liver, lungs, and other tissues in the body and can also made in the laboratory. Heparin may be injected into muscle or blood to prevent or break up blood clots. It is a type of anticoagulant.